004310.KO Hyundai Pharm

Healthcare Pharmaceuticals Korea Stock Exchange
6,630 KRW
Close of Nov 4, 2026
3,490 15,916
Market cap
KRW 205B
P/E
142.5x
P/B
1.53x
ROE
3.5%
Dividend yield
0.38%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Aug 2026.

Is 004310.KO undervalued?

Graham number

The Graham number of Hyundai Pharm cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hyundai Pharm fundamental analysis

No fundamental analysis for Hyundai Pharm yet.

Hyundai Pharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hyundai Pharm

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilator…

Full company profile